Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Oramed Pharmaceuticals Inc. (ORMP) had Weighted-Average Shares Outstanding (Diluted) of 40.83M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-19.06M |
|
-- |
|
-- |
|
$12.78M |
|
$-12.78M |
|
$-3.14M |
|
$-15.92M |
|
$-15.92M |
|
$-19.10M |
|
$-19.10M |
|
$-19.10M |
|
$-19.10M |
|
$-12.78M |
|
$-12.59M |
|
40.83M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
40.83M |
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$143.22M |
|
$0.70M |
|
$12.06M |
|
$155.28M |
|
$5.68M |
|
-- |
|
$4.25M |
|
$9.93M |
|
$145.35M |
|
$145.35M |
|
$145.35M |
|
39.92M |
|
| Cash Flow Statement Financials | |
$-8.41M |
|
$105.82M |
|
$-52.04M |
|
$9.05M |
|
$54.42M |
|
$45.37M |
|
$4.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.14% |
|
-13.14% |
|
-12.30% |
|
-13.14% |
|
$3.64 |
|
$-0.21 |
|
$-0.21 |
|